Fox KR - Search Results

1

Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.

Silber JH, Rosenbaum PR, Ross RN, Reiter JG, Niknam BA, Hill AS, Bongiorno DM, Shah SA, Hochman LL, Even-Shoshan O, Fox KR. Silber JH, et al. Among authors: fox kr. Milbank Q. 2018 Dec;96(4):706-754. doi: 10.1111/1468-0009.12355. Milbank Q. 2018. PMID: 30537364 Free PMC article.

2

First-cycle blood counts and subsequent neutropenia, dose reduction, or delay in early-stage breast cancer therapy.

Silber JH, Fridman M, DiPaola RS, Erder MH, Pauly MV, Fox KR. Silber JH, et al. Among authors: fox kr. J Clin Oncol. 1998 Jul;16(7):2392-400. doi: 10.1200/JCO.1998.16.7.2392. J Clin Oncol. 1998. PMID: 9667256

3

Modeling the cost-effectiveness of granulocyte colony-stimulating factor use in early-stage breast cancer.

Silber JH, Fridman M, Shpilsky A, Even-Shoshan O, Smink DS, Jayaraman J, Fox KR, Pauly MV. Silber JH, et al. Among authors: fox kr. J Clin Oncol. 1998 Jul;16(7):2435-44. doi: 10.1200/JCO.1998.16.7.2435. J Clin Oncol. 1998. PMID: 9667261

4

Characteristics associated with differences in survival among black and white women with breast cancer.

Silber JH, Rosenbaum PR, Clark AS, Giantonio BJ, Ross RN, Teng Y, Wang M, Niknam BA, Ludwig JM, Wang W, Even-Shoshan O, Fox KR. Silber JH, et al. Among authors: fox kr. JAMA. 2013 Jul 24;310(4):389-97. doi: 10.1001/jama.2013.8272. JAMA. 2013. PMID: 23917289 Free article.

5

Differences in breast cancer survival by race--reply.

Silber JH, Rosenbaum PR, Fox KR. Silber JH, et al. Among authors: fox kr. JAMA. 2013 Dec 11;310(22):2457. doi: 10.1001/jama.2013.281075. JAMA. 2013. PMID: 24327042 No abstract available.

6

Racial disparities in colon cancer survival: a matched cohort study.

Silber JH, Rosenbaum PR, Ross RN, Niknam BA, Ludwig JM, Wang W, Clark AS, Fox KR, Wang M, Even-Shoshan O, Giantonio BJ. Silber JH, et al. Among authors: fox kr. Ann Intern Med. 2014 Dec 16;161(12):845-54. doi: 10.7326/M14-0900. Ann Intern Med. 2014. PMID: 25506853

7

The influence of young age on outcome in early stage breast cancer.

Fowble BL, Schultz DJ, Overmoyer B, Solin LJ, Fox K, Jardines L, Orel S, Glick JH. Fowble BL, et al. Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):23-33. doi: 10.1016/0360-3016(94)90515-0. Int J Radiat Oncol Biol Phys. 1994. PMID: 8083119

8

Impact of 21-Gene Expression Assay on Clinical Outcomes in Node-Negative ≤ T1b Breast Cancer.

Pomponio M, Keele L, Hilt E, Burkbauer L, Goldbach M, Nazarian S, Fox K, Tchou J. Pomponio M, et al. Ann Surg Oncol. 2020 May;27(5):1671-1678. doi: 10.1245/s10434-019-08028-w. Epub 2019 Nov 4. Ann Surg Oncol. 2020. PMID: 31686348

9

Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience.

Pomponio MK, Burkbauer L, Goldbach M, Nazarian SM, Xie F, Clark AS, Matro JM, Fox KR, Shulman LN, Keele LJ, Tchou J. Pomponio MK, et al. Among authors: fox kr. J Surg Oncol. 2020 Mar;121(3):447-455. doi: 10.1002/jso.25814. Epub 2020 Jan 9. J Surg Oncol. 2020. PMID: 31919848 Clinical Trial.

10

Breast cancer: incidence, risks, and primary and adjuvant therapy.

Fox KR. Fox KR. Semin Roentgenol. 1993 Jul;28(3):182-92. doi: 10.1016/s0037-198x(05)80078-1. Semin Roentgenol. 1993. PMID: 8211228 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

491 results

Search Page